In-hospital and Long-term Outcomes for Percutaneous Chronic Total Coronary Occlusion Revascularization in a High-volume, Multi-operator Program (Perspective)
PERSPECTIVE: Percutaneous Revascularization at Piedmont for Chronic Total Occlusions Survey
Sponsor: Piedmont Healthcare
This observational or N/A phase trial investigates Ischemic Heart Disease and is currently completed. Piedmont Healthcare leads this study, which shows 8 recorded versions since 2013 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
May 2019 — Jan 2021 [monthly]
Completed
-
Jun 2018 — May 2019 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
-
Jan 2017 — Dec 2017 [monthly]
Unknown Status NA
First recorded
Aug 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Piedmont Healthcare
For direct contact, visit the study record on ClinicalTrials.gov .